Detalhe da pesquisa
1.
Non-IL-2-blocking anti-CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic effects with anti-CTLA-4 therapy.
Int J Cancer
; 154(7): 1285-1297, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38180065
2.
Preparation and characterization of a high-afï¬nity monoclonal antibody against nerve growth factor.
Protein Expr Purif
; 189: 105966, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34627999
3.
Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatment.
Eur J Med Chem
; 274: 116521, 2024 Aug 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38820853
4.
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.
J Hematol Oncol
; 15(1): 177, 2022 12 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36581954
5.
Effective antitumor activity of 5T4-specific CAR-T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo.
MedComm (2020)
; 1(3): 338-350, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34766126
6.
Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
Eur J Med Chem
; 199: 112364, 2020 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32402935
7.
Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.
Mol Oncol
; 13(9): 1855-1873, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31116512